AAAAAA
Results:
1-10
|
Results: 10
Authors:
RAVN V
HAVSTEEN H
THORPE SM
Citation: V. Ravn et al., IMMUNOHISTOCHEMICAL EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORSIN PARAFFIN-EMBEDDED, FORMALIN-FIXED ENDOMETRIAL TISSUES - COMPARISONWITH ENZYME-IMMUNOASSAY AND IMMUNOHISTOCHEMICAL ANALYSIS OF FROZEN TISSUE, Modern pathology, 11(8), 1998, pp. 709-715
Authors:
KELDSEN N
MADSEN EL
HAVSTEEN H
KAMBY C
LAURSEN L
SANDBERG E
Citation: N. Keldsen et al., ORAL TREOSULFAN AS 2ND-LINE TREATMENT IN PLATINUM-RESISTANT OVARIAN-CANCER - A PHASE-II STUDY, Gynecologic oncology, 69(2), 1998, pp. 100-102
Authors:
STAUSBOLGRON B
HAVSTEEN H
OVERGAARD J
Citation: B. Stausbolgron et al., FIBROBLAST GROWTH IN THE SOFT AGAR CLONOGENIC-ASSAY FOR CERVIX CANCERRADIOSENSITIVITY, British Journal of Cancer, 78(4), 1998, pp. 550-551
Authors:
JAKOBSEN A
BERTELSEN K
ANDERSEN JE
HAVSTEEN H
JAKOBSEN P
MOELLER KA
NIELSEN K
SANDBERG E
STROEYER I
Citation: A. Jakobsen et al., DOSE-EFFECT STUDY OF CARBOPLATIN IN OVARIAN-CANCER - A DANISH OVARIAN-CANCER GROUP-STUDY, Journal of clinical oncology, 15(1), 1997, pp. 193-198
Authors:
SENGELOV L
KLINTORP S
HAVSTEEN H
KAMBY C
HANSEN SL
VONDERMAASE H
Citation: L. Sengelov et al., TREATMENT OUTCOME FOLLOWING RADIOTHERAPY IN ELDERLY PATIENTS WITH BLADDER-CANCER, Radiotherapy and oncology, 44(1), 1997, pp. 53-58
Authors:
HAVSTEEN H
KJAER M
Citation: H. Havsteen et M. Kjaer, ANTIEMETIC TREATMENT WITH 2 DIFFERENT DOSES OF METHYLPREDNISOLONE IN BREAST-CANCER PATIENTS - A DOUBLE-BLIND RANDOMIZED CROSS-OVER STUDY WITH EVALUATION OF EFFICACY PARAMETERS, Anti-cancer drugs, 7(5), 1996, pp. 535-542
Authors:
HAVSTEEN H
BERTELSEN K
GADEBERG CC
JACOBSEN A
KAMBY C
SANDBERG E
SENGELOV L
Citation: H. Havsteen et al., A PHASE-2 STUDY WITH EPIRUBICIN AS 2ND-LINE TREATMENT OF PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 63(2), 1996, pp. 210-215
Authors:
VESTERMARK V
HAVSTEEN H
KAMBY C
Citation: V. Vestermark et al., LACK OF EFFECT FROM MITOMYCIN-C PLUS 5-FLUOROURACIL IN PLATIN-RESISTANT OVARIAN-CANCER - A PHASE-II STUDY, International journal of gynecological cancer, 5(5), 1995, pp. 386-389
Authors:
HAVSTEEN H
ANDERSEN LJ
KJAER M
DALMARK M
Citation: H. Havsteen et al., ON-DEMAND ANTIEMETIC TREATMENT WITH THE SEROTONINE ANTAGONIST TROPISETRON IN CISPLATIN-TREATED CANCER-PATIENTS, Anti-cancer drugs, 5(4), 1994, pp. 410-418
Authors:
SORBE B
ANDERSSON H
SCHMIDT M
SODERBERG M
HOGBERG T
WERNSTEDT L
JANSON ET
EHRNSTROM B
KJAER M
HAVSTEEN H
OVERGAARD M
SANDBERG E
FLANDER M
HEIKKINEN M
NIKKANEN V
Citation: B. Sorbe et al., TROPISETRON (NAVOBAN) IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - THE NORDIC EXPERIENCE, Supportive care in cancer, 2(6), 1994, pp. 393-399
Risultati:
1-10
|